LinkedIn Icon
April 3-5, 2019 | Boston, MA

56 Expert Speakers  3 Streams  12+ Hours of Networking

Join the world’s largest meeting of non-alcoholic steatohepatitis stakeholders at industry’s most comprehensive NASH drug development conference: the 3rd Annual NASH Summit (April 2-4 2019, Boston, MA).

Across 3 days and parallel tracks of learning, the 3rd Annual NASH Summit will cover every element of NASH drug development from early discovery to late stage clinical development. Providing an unparalleled learning and networking experience; this exclusive forum is the unrivalled opportunity to network with 300 drug developers from 140 organizations and accelerate the development of your NASH candidate.

  • Exploring the scientific rationale around mechanisms of action and reviewing the latest advances in strategies for effective combination therapies
  • Confidently enrolling and stratifying patients onto your clinical trials using multiple biomarkers and non-invasive technologies to diagnose and assess disease regression/progression
  • Robustly translating into clinical development by improving the predictability of preclinical models

With a 60+ experts on the speaking faculty due to be released save dates for the definitive congress in the NASH conference calendar, and register your interest to be the first to receive the finalized program!

“Well planned, and executed. Top notch organization. Gold standard of focused conferences.”
BioTelemetry Research

“Best meeting for industries and valuable information. This meeting makes my understanding for current situation and future perspectives deeper.”
Shionogi Co & Ltd

An excellent opportunity to find out what other pharma are doing and what’s emerging. Very valuable."
AstraZeneca

 
highlights for 2018
Media Partner